Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
22.97
-0.30 (-1.29%)
Mar 26, 2026, 11:30 AM CST

SHA:600332 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,9832,8354,0563,9673,720
Depreciation & Amortization
865.94875.24929.44743.83676.99
Other Amortization
89.9160.9655.8849.8343.53
Loss (Gain) From Sale of Assets
-107.74-11.12-12.03-0.69-0.69
Asset Writedown & Restructuring Costs
3.922.93-0.427.063.08
Loss (Gain) From Sale of Investments
-416.4539.18-288.71-417.58-390.47
Provision & Write-off of Bad Debts
102.0958.8173.5354.5595.1
Other Operating Activities
556.97608.18660.47715.79659.84
Change in Accounts Receivable
-2,542-255.91-417.27-1,992-1,627
Change in Inventory
-351.71-1,314-835.03-242.22-673.65
Change in Accounts Payable
-1,474602.7-66.124,1213,158
Operating Cash Flow
-232.463,4424,1046,9995,673
Operating Cash Flow Growth
--16.11%-41.37%23.36%869.52%
Capital Expenditures
-1,240-1,128-1,628-1,384-1,255
Sale of Property, Plant & Equipment
120.332.3613.931.496.61
Cash Acquisitions
2.26-1.57-147.67-1.39
Divestitures
-0.98---32.57
Investment in Securities
-3,380-5,053-1,885-6,23342.79
Other Investing Activities
490.7216.09384.46214.82242.77
Investing Cash Flow
-4,007-5,964-3,115-7,253-931.57
Short-Term Debt Issued
299.98-299.96599.91-
Long-Term Debt Issued
12,6859,9549,6049,6968,826
Total Debt Issued
12,9859,9549,90410,2968,826
Short-Term Debt Repaid
---900--
Long-Term Debt Repaid
-11,387-8,648-9,646-8,422-8,943
Total Debt Repaid
-11,387-8,648-10,546-8,422-8,943
Net Debt Issued (Repaid)
1,5981,306-642.151,874-116.76
Common Dividends Paid
-1,648-2,251-1,585-1,491-1,266
Other Financing Activities
539.04-61.59249.35-337.16-111.17
Financing Cash Flow
489.35-1,006-1,97845.95-1,494
Foreign Exchange Rate Adjustments
3.857.148.08-0.50.28
Net Cash Flow
-3,747-3,521-981.16-208.673,248
Free Cash Flow
-1,4722,3142,4755,6154,419
Free Cash Flow Growth
--6.50%-55.92%27.08%-
Free Cash Flow Margin
-1.90%3.09%3.28%7.93%6.40%
Free Cash Flow Per Share
-0.911.421.523.452.72
Cash Income Tax Paid
2,8222,7293,1402,7592,873
Levered Free Cash Flow
-2,421838.991,1693,9471,963
Unlevered Free Cash Flow
-2,1701,1001,4484,2192,224
Change in Working Capital
-4,317-1,028-1,3721,879860.49
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.